Cleerly Overview

  • Founded
  • 2017
Founded
  • Status
  • Private
  • Employees
  • 60
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $43M
Latest Deal Amount
  • Investors
  • 10

Cleerly General Information

Description

Developer of a healthcare platform designed to create a new standard of care for coronary artery disease. The company's platform has a non-invasive, AI-driven approach that supports the understanding of plaques and offers comprehensive quantification and characterization of plaque buildup in the heart arteries, enabling healthcare providers to drastically improve the identification of at-risk patients for early treatment and prevention of heart attacks in a cost-effective manner.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Services
Primary Office
  • 101 Greenwich Street
  • New York, NY 10006
  • United States
+1 (646) 000-0000

Cleerly Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cleerly Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series B) 21-Jun-2021 $43M 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 03-Apr-2020 000.00 000.00 000.00 Completed Generating Revenue
To view Cleerly’s complete valuation and funding history, request access »

Cleerly Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
To view Cleerly’s complete cap table history, request access »

Cleerly Patents

Cleerly Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210241455-A1 Systems, methods, and devices for medical image analysis, diagnosis, risk stratification, decision making and/or disease tracking Pending 07-Jan-2020 0000000000
US-11094061-B1 Systems, methods, and devices for medical image analysis, diagnosis, risk stratification, decision making and/or disease tracking Active 07-Jan-2020 0000000000 000
US-20210241454-A1 Systems, methods, and devices for medical image analysis, diagnosis, risk stratification, decision making and/or disease tracking Granted 07-Jan-2020 0000000000
US-20210256695-A1 Systems, methods, and devices for medical image analysis, diagnosis, risk stratification, decision making and/or disease tracking Granted 07-Jan-2020 0000000000
US-20210256694-A1 Systems, methods, and devices for medical image analysis, diagnosis, risk stratification, decision making and/or disease tracking Granted 07-Jan-2020 G06T7/0012

Cleerly Executive Team (7)

Name Title Board Seat Contact Info
James Min MD Founder, Chief Executive Officer, President & Board Member
Brandon Atkinson Chief Operating Officer
Kimberly McCombs Chief Strategy Officer
Nick Nieslanik Chief Technology Officer
Jim Hartman Chief Revenue Officer
You’re viewing 5 of 7 executive team members. Get the full list »

Cleerly Board Members (7)

Name Representing Role Since
Glenn Steele Jr. Self Board Member 000 0000
James Min MD Cleerly Founder, Chief Executive Officer, President & Board Member 000 0000
Justin Klein MD Self Board Member 000 0000
Kevin King Self Board Member 000 0000
Roy Beveridge MD Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Cleerly Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cleerly Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
American College of Cardiology Foundation Limited Partner Minority 000 0000 000000 0
Cigna Ventures Corporate Venture Capital Minority 000 0000 000000 0
digiTx Venture Capital Minority 000 0000 000000 0
New Leaf Venture Venture Capital Minority 000 0000 000000 0
Vensana Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »